Cargando…

Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study

OBJECTIVES: As global efforts continue toward the target of eliminating viral hepatitis by 2030, the emergence of acute hepatitis of unspecified aetiology (HUA) remains a concern. This study assesses the overall trends and changes in spatiotemporal patterns in HUA in China from 2004 to 2021. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Na, Guo, Xiangyu, Wang, Lan, Zhou, Hongming, Gong, Lei, Miao, Ziping, Chen, Yijuan, Qin, Shuwen, Yu, Zhao, Liu, Shelan, Wang, Supen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196104/
https://www.ncbi.nlm.nih.gov/pubmed/37213628
http://dx.doi.org/10.3389/fpubh.2023.1177965
_version_ 1785044271382921216
author Zhao, Na
Guo, Xiangyu
Wang, Lan
Zhou, Hongming
Gong, Lei
Miao, Ziping
Chen, Yijuan
Qin, Shuwen
Yu, Zhao
Liu, Shelan
Wang, Supen
author_facet Zhao, Na
Guo, Xiangyu
Wang, Lan
Zhou, Hongming
Gong, Lei
Miao, Ziping
Chen, Yijuan
Qin, Shuwen
Yu, Zhao
Liu, Shelan
Wang, Supen
author_sort Zhao, Na
collection PubMed
description OBJECTIVES: As global efforts continue toward the target of eliminating viral hepatitis by 2030, the emergence of acute hepatitis of unspecified aetiology (HUA) remains a concern. This study assesses the overall trends and changes in spatiotemporal patterns in HUA in China from 2004 to 2021. METHODS: We extracted the incidence and mortality rates of HUA from the Public Health Data Center, the official website of the National Health Commission of the People’s Republic of China, and the National Notifiable Infectious Disease Surveillance System from 2004 to 2021. We used R software, ArcGIS, Moran’s statistical analysis, and joinpoint regression to examine the spatiotemporal patterns and annual percentage change in incidence and mortality of the HUA across China. RESULTS: From 2004 to 2021, a total of 707,559 cases of HUA have been diagnosed, including 636 deaths. The proportion of HUA in viral hepatitis gradually decreased from 7.55% in 2004 to 0.72% in 2021. The annual incidence of HUA decreased sharply from 6.6957 per 100,000 population in 2004 to 0.6302 per 100,000 population in 2021, with an average annual percentage change (APC) reduction of −13.1% (p < 0.001). The same result was seen in the mortality (APC, −22.14%, from 0.0089/100,000 in 2004 to 0.0002/100,000 in 2021, p < 0.001). All Chinese provinces saw a decline in incidence and mortality. Longitudinal analysis identified the age distribution in the incidence and mortality of HUA did not change and was highest in persons aged 15–59 years, accounting for 70% of all reported cases. During the COVID-19 pandemic, no significant increase was seen in pediatric HUA cases in China. CONCLUSION: China is experiencing an unprecedented decline in HUA, with the lowest incidence and mortality for 18 years. However, it is still important to sensitively monitor the overall trends of HUA and further improve HUA public health policy and practice in China.
format Online
Article
Text
id pubmed-10196104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101961042023-05-20 Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study Zhao, Na Guo, Xiangyu Wang, Lan Zhou, Hongming Gong, Lei Miao, Ziping Chen, Yijuan Qin, Shuwen Yu, Zhao Liu, Shelan Wang, Supen Front Public Health Public Health OBJECTIVES: As global efforts continue toward the target of eliminating viral hepatitis by 2030, the emergence of acute hepatitis of unspecified aetiology (HUA) remains a concern. This study assesses the overall trends and changes in spatiotemporal patterns in HUA in China from 2004 to 2021. METHODS: We extracted the incidence and mortality rates of HUA from the Public Health Data Center, the official website of the National Health Commission of the People’s Republic of China, and the National Notifiable Infectious Disease Surveillance System from 2004 to 2021. We used R software, ArcGIS, Moran’s statistical analysis, and joinpoint regression to examine the spatiotemporal patterns and annual percentage change in incidence and mortality of the HUA across China. RESULTS: From 2004 to 2021, a total of 707,559 cases of HUA have been diagnosed, including 636 deaths. The proportion of HUA in viral hepatitis gradually decreased from 7.55% in 2004 to 0.72% in 2021. The annual incidence of HUA decreased sharply from 6.6957 per 100,000 population in 2004 to 0.6302 per 100,000 population in 2021, with an average annual percentage change (APC) reduction of −13.1% (p < 0.001). The same result was seen in the mortality (APC, −22.14%, from 0.0089/100,000 in 2004 to 0.0002/100,000 in 2021, p < 0.001). All Chinese provinces saw a decline in incidence and mortality. Longitudinal analysis identified the age distribution in the incidence and mortality of HUA did not change and was highest in persons aged 15–59 years, accounting for 70% of all reported cases. During the COVID-19 pandemic, no significant increase was seen in pediatric HUA cases in China. CONCLUSION: China is experiencing an unprecedented decline in HUA, with the lowest incidence and mortality for 18 years. However, it is still important to sensitively monitor the overall trends of HUA and further improve HUA public health policy and practice in China. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196104/ /pubmed/37213628 http://dx.doi.org/10.3389/fpubh.2023.1177965 Text en Copyright © 2023 Zhao, Guo, Wang, Zhou, Gong, Miao, Chen, Qin, Yu, Liu and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Zhao, Na
Guo, Xiangyu
Wang, Lan
Zhou, Hongming
Gong, Lei
Miao, Ziping
Chen, Yijuan
Qin, Shuwen
Yu, Zhao
Liu, Shelan
Wang, Supen
Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
title Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
title_full Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
title_fullStr Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
title_full_unstemmed Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
title_short Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study
title_sort changing spatiotemporal patterns for hepatitis of unspecified aetiology in china, 2004–2021: a population-based surveillance study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196104/
https://www.ncbi.nlm.nih.gov/pubmed/37213628
http://dx.doi.org/10.3389/fpubh.2023.1177965
work_keys_str_mv AT zhaona changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT guoxiangyu changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT wanglan changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT zhouhongming changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT gonglei changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT miaoziping changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT chenyijuan changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT qinshuwen changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT yuzhao changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT liushelan changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy
AT wangsupen changingspatiotemporalpatternsforhepatitisofunspecifiedaetiologyinchina20042021apopulationbasedsurveillancestudy